Nothing Special   »   [go: up one dir, main page]

PA8552001A1 - 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS - Google Patents

1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS

Info

Publication number
PA8552001A1
PA8552001A1 PA8552001A PA8552001A PA8552001A1 PA 8552001 A1 PA8552001 A1 PA 8552001A1 PA 8552001 A PA8552001 A PA 8552001A PA 8552001 A PA8552001 A PA 8552001A PA 8552001 A1 PA8552001 A1 PA 8552001A1
Authority
PA
Panama
Prior art keywords
hypertension
rent
angina
diabetes
description
Prior art date
Application number
PA8552001A
Other languages
Spanish (es)
Inventor
Hartmut Strobel
Paulus Wohlfart
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Priority to PA8552001A priority Critical patent/PA8552001A1/en
Publication of PA8552001A1 publication Critical patent/PA8552001A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A COMPUESTOS DE FORMULA (1), DONDE R1-R4 TIENEN LOS MISMOS SIGNIFICADOS DADOS EN LA DESCRIPCION, A ES CH2, CHOH O CH-(ALQUILO C1-C3),B Y C SON, INDEPENDIENTEMENTE, CH2 O CH-(ALQUILO C1-C3), Y R5 ES UN GRUPO ARILO O HETEROARILO, OPCIONALMENTE SUSTITUIDO CON LOS SUSTITUYENTES ENUMERADOS EN LA DESCRIPCION. ESTOS COMPUESTOS SON UTILES PARA LA FABRICACION DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES, ANGINA DE PECHO ESTABLE E INESTABLE, CARDIOPATIA CORONARIA, ANGINA DE PRINZMETAL, SINDROME AGUDO DE LAS CORONARIAS, INSUFICI3ENCIA CARDIACA, INFARTO DE MIOCARDIO, ATAQUE DE APOPLEJIA, TROMBOSIS, ENFERMEDAD OCLUSIVA DE LAS ARTERIAS PERIFERICAS, DISFUNCION ENDOTELIAL, ATEROSCLEROSIS, RESTENOSIS, DAÑO ENDOTELIAL DESPUES DE PTCA, HIPERTENSION, HIPERTENSION ESENCIAL, HIPERTENSION PULMONAR, HIPERTENSION SECUNDARIA, HIPERTENSION RENOVASCULAR, GLOMERULONEFRITIS CRONICA, DISFUNCION ERECTIL, ARRITMIA VENTRICULAR, DIABETES, COMPLICACIONES DE LA DIABETES, NEFROPATIA, RETINOPATIA, ANGIOGENESIS, ASMA BRONQUIAL, INSUFICIENCIA RENAL CRONICA, CIRROSIS HEPATICA, OSTEOROPOROSIS, O FUNCIONAMIENTO LIMITADO DE LA MEMORIA O CAPACIDAD DE APRENDIZAJE LIMITADA, O DISMINUCION DEL RIESGO CARDIOVASCULAR DE LAS MUJERES MENOPAUSICAS O DESPUES DE INGERIR CONTRACEPTIVOS.THIS INVENTION REFERS TO FORMULA COMPOUNDS (1), WHERE R1-R4 HAS THE SAME MEANINGS GIVEN IN THE DESCRIPTION, A IS CH2, CHOH OR CH- (C1-C3 RENT), BYC SON, INDEPENDENTLY, CH2 OR CH- (RENT C1-C3), AND R5 IS AN ARILO OR HETEROARILO GROUP, OPTIONALLY REPLACED WITH THE SUBSTITUTES LISTED IN THE DESCRIPTION. THESE COMPOUNDS ARE USEFUL FOR THE MANUFACTURE OF MEDICINES FOR THE TREATMENT OF CARDIOVASCULAR DISEASES, ANGINA OF STABLE AND UNSTABLE CHEST, CORONARY CARDIOPATIA, ANGINA DE PRINZMETAL, ACUTE SYMPOSIUM OF CORONARY DISEASE, CARDIIOUSNESS, BODY CARDIOBILITY, CARDIOPATHY ADDITIONALITY occlusive ARTERY peripheral endothelial dysfunction, atherosclerosis, restenosis, DAMAGE ENDOTHELIAL after PTCA, hypertension, essential hypertension, hypertension PULMONARY hYPERTENSION SECONDARY, renovascular hypertension, chronic glomerulonephritis, erectile dysfunction, ventricular arrhythmia, diabetes, complications of diabetes, nephropathy , RETINOPATIA, ANGIOGENESIS, BRONCHIAL ASTHMA, CHRONIC RENAL INSUFFICIENCY, HEPATIC CIRROSIS, OSTEOROPOROSIS, OR LIMITED FUNCTIONING OF THE MEMORY OR LIMITED LEARNING CAPACITY, OR DECREASE OF THE CARDIOVASCULAR RISK UNDER THE WRONG OPENING OF THE WOMEN.

PA8552001A 2002-08-06 2002-08-06 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS PA8552001A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PA8552001A PA8552001A1 (en) 2002-08-06 2002-08-06 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PA8552001A PA8552001A1 (en) 2002-08-06 2002-08-06 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS

Publications (1)

Publication Number Publication Date
PA8552001A1 true PA8552001A1 (en) 2004-02-16

Family

ID=40257236

Family Applications (1)

Application Number Title Priority Date Filing Date
PA8552001A PA8552001A1 (en) 2002-08-06 2002-08-06 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS

Country Status (1)

Country Link
PA (1) PA8552001A1 (en)

Similar Documents

Publication Publication Date Title
SV2006000883A (en) INDANIL ACILATED AMINAS AND ITS USE AS PHARMACOS
UY27164A1 (en) 1, 2, 3, 4- TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS
PE20020884A1 (en) 4-FLUORO-N-INDAN-2-IL-BENZAMIDE AND ITS USE AS A PHARMACEUTICAL PRODUCT
BR0207197A (en) Acylated 6,7,8,9-tetrahydro-5h-benzocycloeptenyl amines and their use as a pharmaceutical agent
CY1111363T1 (en) TRICYCLE COMPETITOR THROMVIN RECEPTORS
PA8812801A1 (en) DERIVATIVES OF CARBOXAMIDES AZABICICLICAS, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
NO20076502L (en) Pyrrolopyridines useful as inhibitors of protein kinase
CL2012000981A1 (en) Compounds derived from 5-ethynyl-2 - [(3-phenyl-1h-pyrazolo [3.4-d] pyrimidin-1-yl) methyl] quinazolin-4 (3h) -one, phosphoinositide 3-kinase inhibitors intermediate compounds; without pharmacological action; pharmaceutical composition; Useful in the treatment of COPD, asthma, cystic and pulmonary fibrosis, sarcoidosis, among others.
CY1108744T1 (en) 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepine-3-yl-piperidines as CGRP antagonists
DK1532269T3 (en) 1L1RL-1 as a marker of cardiovascular disease
CY1113792T1 (en) PHARMACEUTICAL COMPOSITIONS OF CONTROLLED FREQUENCY INCLUDED FUMAR ACID ESTE
HN2002000317A (en) PDE9 INHIBITORS FOR TREATMENT OF CARDIOVASCULAR DISORDERS
PT1406898E (en) SUBSTITUTED PIPERAZINE COMPOUNDS AND ITS USE AS OXIDACAO INHIBITORS OF FATTY ACIDS
ECSP024244A (en) USE OF (Z) -2-CYANO-3-HYDROXY-BUT-2-ENOIC ACID (4´-TRIFLUOROMETHYLPHENYL) -AMIDE FOR THE TREATMENT OF MULTIPLE SCLEROSIS
AR055562A1 (en) 1,3 OXAZINE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THAT UNDERSTAND THEM.
ES2421556T3 (en) Use of cardiac hormones to diagnose the risk of cardiovascular complications as a result of cardiotoxic medications
PA8552001A1 (en) 1,2,3,4-TETRAHYDRONAFTIL ACILATED AMINES AND ITS USE AS PHARMACOS
NO20075209L (en) Substituted aryl 1,4-pyrazine derivatives
PA8552101A1 (en) 6,7,8,9-TETRAHIDRO-5H-BENZOCICLOHEPTENIL ACILATED AMINES AND ITS USE AS PHARMACOS
PA8551901A1 (en) INDANIL ACILATED AMINAS AND ITS USE AS PHARMACOS
SV2006000884A (en) 6,7,8,9-TETRAHIDRO-5H-BENZOCICLOHEPTENIL ACILATED AMINES AND ITS USE AS PHARMACOS
PA8683901A1 (en) AMIDAS REPLACED WITH HETEROARILO THAT INCLUDE A SATURATED LINKER GROUP, AND ITS USE AS PHARMACEUTICAL AGENTS
SE0401539D0 (en) New compounds
SE0401540D0 (en) New compounds
PE20030587A1 (en) DERIVATIVES OF PYRIMIDINE BENZENOSULFONAMIDE AS ANTAGONISTS OF ALPHA-2ß-ADRENORECEPTOR